US Patent Issued to The Trustees of Columbia University in the City of New York on March 4 for "Treatment of cognitive disorders using nitazoxanide (NTZ), nitazoxanide (NTZ) analogs, and metabolites thereof" (New Jersey, New York Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,635, issued on March 4, was assigned to The Trustees of Columbia University in the City of New York (New York).

"Treatment of cognitive disorders using nitazoxanide (NTZ), nitazoxanide (NTZ) analogs, and metabolites thereof" was invented by Tae-Wan Kim (East Brunswick, N.J.) and Gina Finan (Brooklyn, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and pharmaceutical compositions effective for treating cognitive disorders are described. The compounds and pharmaceutical compositions described include Nitazoxanide (NTZ), Nitazoxanide (NTZ) analogs, Nitazoxanide (NTZ) metabolites, or Nitazoxanide (NTZ) metabolite analogs. Methods of treati...